{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:30:45Z","timestamp":1793413845650,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7869","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,7,29]]},"DOI":"10.1038\/s41586-021-03673-2","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T06:15:03Z","timestamp":1622700903000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants"],"prefix":"10.1038","volume":"595","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8347-0013","authenticated-orcid":false,"given":"Zhiqiang","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-016X","authenticated-orcid":false,"given":"Xuping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-4144","authenticated-orcid":false,"given":"Paul R.","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio E.","family":"Muruato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepal","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8803-7606","authenticated-orcid":false,"given":"Vineet D.","family":"Menachery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-An","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-9223","authenticated-orcid":false,"given":"Bruce A.","family":"Keyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-2180","authenticated-orcid":false,"given":"Ningyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-9918","authenticated-orcid":false,"given":"Stephen F.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-1616","authenticated-orcid":false,"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-2335","authenticated-orcid":false,"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"3673_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20789-7","volume":"12","author":"Z Ku","year":"2021","unstructured":"Ku, Z. et al. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat. Commun. 12, 469 (2021).","journal-title":"Nat. Commun."},{"key":"3673_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","volume":"27","author":"CK Wibmer","year":"2021","unstructured":"Wibmer, C. K. et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. 27, 622\u2013625 (2021).","journal-title":"Nat. Med."},{"key":"3673_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"3673_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850\u2013854 (2021).","journal-title":"Science"},{"key":"3673_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"3673_CR6","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","volume":"8","author":"E Pujadas","year":"2020","unstructured":"Pujadas, E. et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir. Med. 8, e70 (2020).","journal-title":"Lancet Respir. Med."},{"key":"3673_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev-immunol-032414-112315","volume":"34","author":"A Iwasaki","year":"2016","unstructured":"Iwasaki, A. Exploiting mucosal immunity for antiviral vaccines. Annu. Rev. Immunol. 34, 575\u2013608 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"3673_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/s41587-020-0732-8","volume":"38","author":"L DeFrancesco","year":"2020","unstructured":"DeFrancesco, L. COVID-19 antibodies on trial. Nat. Biotechnol. 38, 1242\u20131252 (2020).","journal-title":"Nat. Biotechnol."},{"key":"3673_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2021","unstructured":"Weinreich, D. M. et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with covid-19. N. Engl. J. Med. 384, 238\u2013251 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3673_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1126\/science.aaz5807","volume":"367","author":"N Kumar","year":"2020","unstructured":"Kumar, N., Arthur, C. P., Ciferri, C. & Matsumoto, M. L. Structure of the secretory immunoglobulin A core. Science 367, 1008\u20131014 (2020).","journal-title":"Science"},{"key":"3673_CR11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.aaz5425","volume":"367","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Structural insights into immunoglobulin M. Science 367, 1014\u20131017 (2020).","journal-title":"Science"},{"key":"3673_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12931-019-1057-3","volume":"20","author":"C Vonarburg","year":"2019","unstructured":"Vonarburg, C. et al. Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respir. Res. 20, 99 (2019).","journal-title":"Respir. Res."},{"key":"3673_CR13","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, eabf1555 (2021).","journal-title":"Sci. Transl. Med."},{"key":"3673_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2015.01.016","volume":"160","author":"RP Galimidi","year":"2015","unstructured":"Galimidi, R. P. et al. Intra-spike crosslinking overcomes antibody evasion by HIV-1. Cell 160, 433\u2013446 (2015).","journal-title":"Cell"},{"key":"3673_CR15","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","volume":"3","author":"J ter Meulen","year":"2006","unstructured":"ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, e237 (2006).","journal-title":"PLoS Med."},{"key":"3673_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nprot.2016.180","volume":"12","author":"BD Weitzner","year":"2017","unstructured":"Weitzner, B. D. et al. Modeling and docking of antibody structures with Rosetta. Nat. Protocols 12, 401\u2013416 (2017).","journal-title":"Nat. Protocols"},{"key":"3673_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","volume":"184","author":"EC Thomson","year":"2021","unstructured":"Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171\u20131187 (2021).","journal-title":"Cell"},{"key":"3673_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","volume":"29","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 29, 477\u2013488 (2021).","journal-title":"Cell Host Microbe"},{"key":"3673_CR19","unstructured":"FDA. Fact sheet for health care providers. Emergency use authorization (EUA) of casirivimab and imdevimab, https:\/\/www.fda.gov\/media\/143892\/download (2020)."},{"key":"3673_CR20","unstructured":"FDA. Fact sheet for health care providers. Emergency use authorization (EUA) of bamlanivimab, https:\/\/www.fda.gov\/media\/143603\/download (2020)."},{"key":"3673_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","volume":"182","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429\u2013446 (2020).","journal-title":"Cell"},{"key":"3673_CR22","first-page":"1843","volume":"323","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Detection of SARS-CoV-2 in different types of clinical specimens. J. Am. Med. Assoc. 323, 1843\u20131844 (2020).","journal-title":"J. Am. Med. Assoc."},{"key":"3673_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"3673_CR24","doi-asserted-by":"publisher","first-page":"F5","DOI":"10.1097\/QAD.0000000000001857","volume":"32","author":"S Gong","year":"2018","unstructured":"Gong, S. et al. Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32, F5\u2013F13 (2018).","journal-title":"AIDS"},{"key":"3673_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/antib9040053","volume":"9","author":"BA Keyt","year":"2020","unstructured":"Keyt, B. A., Baliga, R., Sinclair, A. M., Carroll, S. F. & Peterson, M. S. Structure, function, and therapeutic use of IgM antibodies. Antibodies 9, 53 (2020).","journal-title":"Antibodies"},{"key":"3673_CR26","doi-asserted-by":"publisher","unstructured":"Muruato, A. et al. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV-2 challenge. Preprint at https:\/\/doi.org\/10.1101\/2021.05.03.442357 (2021).","DOI":"10.1101\/2021.05.03.442357"},{"key":"3673_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27, 841\u2013848 (2020).","journal-title":"Cell Host Microbe"},{"key":"3673_CR28","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","volume":"16","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Engineering SARS-CoV-2 using a reverse genetic system. Nat. Protocols 16, 1761\u20131784 (2021).","journal-title":"Nat. Protocols"},{"key":"3673_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2010.05.003","volume":"359","author":"K Vorauer-Uhl","year":"2010","unstructured":"Vorauer-Uhl, K., Wallner, J., Lhota, G., Katinger, H. & Kunert, R. IgM characterization directly performed in crude culture supernatants by a new simple electrophoretic method. J. Immunol. Methods 359, 21\u201327 (2010).","journal-title":"J. Immunol. Methods"}],"updated-by":[{"DOI":"10.1038\/s41586-025-09953-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03673-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:32:20Z","timestamp":1764311540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":29,"journal-issue":{"issue":"7869","published-print":{"date-parts":[[2021,7,29]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1038\/s41586-021-03673-2","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-09953-5","URL":"https:\/\/doi.org\/10.1038\/s41586-025-09953-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Texas System has filed a patent on the SARS-CoV-2 antibodies and the reverse genetic system and reporter SARS-CoV-2. The University of Texas System and IGM Biosciences have filed a joint patent on the SARS-CoV-2 IgM antibodies. The antibodies are being developed by IGM Biosciences for prophylactic and therapeutic treatment of COVID-19. P.R.H., D.C.N., D.P., S.R., Y-A.C., K.B.C., E.J.H., B.A.K. and S.F.C. are employees of IGM Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}